{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:17:47Z","timestamp":1787501867344,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neurobrucellosis, a serious central nervous system infection caused by Brucella species, presents significant challenges due to its diverse clinical manifestations and the risk of long-term complications and poor outcomes. Identifying predictors of adverse outcomes is critical for improving patient management and overall prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to evaluate the long-term morbidity and mortality associated with neurobrucellosis and to identify key predictors of adverse outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective cohort study of 106 neurobrucellosis patients treated at two major referral centers in Mashhad, Iran, from March 21, 2011, to March 20, 2022. We analyzed clinical, neuroimaging, and laboratory data, and estimated survival probabilities using Kaplan\u2013Meier analysis. Long-term morbidity was evaluated using the Glasgow Outcome Scale.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median age of the cohort was 30\u00a0years (IQR: 21.8\u201346.3). The median length of hospital stay was 11\u00a0days (IQR: 7\u201319.8), with an in-hospital mortality rate of 4.7% (n\u2009=\u20095). Survival probabilities were 92.2% (SE\u2009=\u20090.027) at 1\u00a0month and 90.1% (SE\u2009=\u20090.030) at 6 months. The median follow-up duration was 52\u00a0months (IQR: 35\u201377). At follow-up, 23.5% (n\u2009=\u200920) of patients had an unfavorable outcome based on the Glasgow Outcome Scale. Predictors of mortality included older age, altered level of consciousness, seizures, elevated body temperature on admission, and white matter changes on neuroimaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Neurobrucellosis is associated with significant long-term morbidity and mortality. Key predictors of mortality include older age, altered level of consciousness, seizures, elevated body temperature on admission, and white matter changes. Identifying these predictors can help in targeting therapeutic strategies and improving patient outcomes through early intervention and close monitoring.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41182-025-00680-1","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T07:02:57Z","timestamp":1736924577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neurobrucellosis: a retrospective cohort of 106 patients"],"prefix":"10.1186","volume":"53","author":[{"given":"Fatemeh","family":"Arazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshte","family":"Sheybani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Taghi","family":"Farzadfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid Khadem","family":"Rezaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"1","key":"680_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s41182-022-00472-x","volume":"50","author":"H Naderi","year":"2022","unstructured":"Naderi H, Sheybani F, Parsa A, et al. Neurobrucellosis: report of 54 cases. Trop Med Health. 2022;50(1):77.","journal-title":"Trop Med Health"},{"key":"680_CR2","doi-asserted-by":"crossref","unstructured":"Sheybani F, Haddad M, Shirazinia M. Epidemiology and etiology of community-acquired CNS infections in Iran: a narrative review. Future Neurol. 2023;18(4):FNL73.","DOI":"10.2217\/fnl-2023-0017"},{"issue":"1","key":"680_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/00207454.2017.1363747","volume":"128","author":"N Zheng","year":"2018","unstructured":"Zheng N, Wang W, Zhang J-T, et al. Neurobrucellosis. Int J Neurosci. 2018;128(1):55\u201362.","journal-title":"Int J Neurosci"},{"issue":"4","key":"680_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.nic.2011.07.008","volume":"21","author":"O Kizilkilic","year":"2011","unstructured":"Kizilkilic O, Calli C. Neurobrucellosis. Neuroimag Clin. 2011;21(4):927\u201337.","journal-title":"Neuroimag Clin"},{"issue":"3","key":"680_CR5","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1128\/AAC.05974-11","volume":"56","author":"H Erdem","year":"2012","unstructured":"Erdem H, Ulu-Kilic A, Kilic S, et al. Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul study. Antimicrob Agents Chemother. 2012;56(3):1523\u20138.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"680_CR6","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/cid\/cit072","volume":"56","author":"T Guven","year":"2013","unstructured":"Guven T, Ugurlu K, Ergonul O, et al. Neurobrucellosis: clinical and diagnostic features. Clin Infect Dis. 2013;56(10):1407\u201312.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"680_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/QCO.0000000000000920","volume":"36","author":"CN Soares","year":"2023","unstructured":"Soares CN, da Silva MTT, Lima MA. Neurobrucellosis. Curr Opin Infect Dis. 2023;36(3):192\u20137.","journal-title":"Curr Opin Infect Dis"},{"key":"680_CR8","doi-asserted-by":"publisher","first-page":"e05672021","DOI":"10.1590\/0037-8682-0567-2021","volume":"55","author":"CN Soares","year":"2022","unstructured":"Soares CN, Angelim AIM, Brand\u00e3o CO, et al. Neurobrucellosis: the great mimicker. Rev Soc Bras Med Trop. 2022;55:e05672021.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"680_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12879-024-09345-6","volume":"24","author":"M Shirazinia","year":"2024","unstructured":"Shirazinia M, Sheybani F, Naderi H, et al. Chronic meningitis in adults: a comparison between neurotuberculosis and neurobrucellosis. BMC Infect Dis. 2024;24(1):441.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"680_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/01616412.2020.1812805","volume":"43","author":"A Esmael","year":"2021","unstructured":"Esmael A, Elsherif M, Elegezy M, et al. Cognitive impairment and neuropsychiatric manifestations of neurobrucellosis. Neurol Res. 2021;43(1):1\u20138.","journal-title":"Neurol Res"},{"key":"680_CR11","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1017\/S0950268824001225","volume":"152","author":"M Haddad","year":"2024","unstructured":"Haddad M, Sheybani F, Shirazinia M, et al. The challenge of etiologic diagnosis of subacute and chronic meningitis: an analysis of 183 patients. Epidemiol Infect. 2024;152:e123.","journal-title":"Epidemiol Infect"},{"issue":"7905","key":"680_CR12","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S0140-6736(75)92830-5","volume":"305","author":"B Jennett","year":"1975","unstructured":"Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet. 1975;305(7905):480\u20134.","journal-title":"Lancet"},{"issue":"1","key":"680_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13613-023-01218-6","volume":"13","author":"N Chekrouni","year":"2023","unstructured":"Chekrouni N, Kroon M, Drost EH, et al. Characteristics and prognostic factors of bacterial meningitis in the intensive care unit: a prospective nationwide cohort study. Ann Intensive Care. 2023;13(1):124.","journal-title":"Ann Intensive Care"},{"issue":"6","key":"680_CR14","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/j.ijid.2009.02.015","volume":"13","author":"HC Gul","year":"2009","unstructured":"Gul HC, Erdem H, Bek S. Overview of neurobrucellosis: a pooled analysis of 187 cases. Int J Infect Dis. 2009;13(6):e339\u201343.","journal-title":"Int J Infect Dis"},{"key":"680_CR15","doi-asserted-by":"crossref","unstructured":"Ceran N, Turkoglu R, Erdem I, et al. Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region. Brazilian J Infect Dis. 2011;15(1):52\u20139.","DOI":"10.1590\/S1413-86702011000100010"},{"issue":"1","key":"680_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/indianjotol.indianjotol_120_23","volume":"30","author":"R Kumar","year":"2024","unstructured":"Kumar R, Alam MN, Munjal SK, et al. Late-onset of labyrinthine dysfunction in chronic brucella-induced encephalitis. Indian J Otol. 2024;30(1):76\u20139.","journal-title":"Indian J Otol"},{"key":"680_CR17","doi-asserted-by":"crossref","unstructured":"Ma C, Li H, Lu S, et al. Ocular lesions in brucella infection: a review of the literature. Infect Drug Resist. 2022;15:7601\u201317.","DOI":"10.2147\/IDR.S394497"},{"issue":"8","key":"680_CR18","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/00365540500466614","volume":"38","author":"B Karakurum Goksel","year":"2006","unstructured":"Karakurum Goksel B, Yerdelen D, Karatas M, et al. Abducens nerve palsy and optic neuritis as initial manifestation in brucellosis. Scand J Infect Dis. 2006;38(8):721\u20135.","journal-title":"Scand J Infect Dis"},{"key":"680_CR19","doi-asserted-by":"crossref","unstructured":"Haddad FS. Pseudotumor cerebri in neurobrucellosis. neurobrucellosis: clinical, diagnostic and therapeutic features. 2016. p. 55\u201360.","DOI":"10.1007\/978-3-319-24639-0_8"},{"issue":"8","key":"680_CR20","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1136\/jnnp.51.8.1017","volume":"51","author":"M Bahemuka","year":"1988","unstructured":"Bahemuka M, Shemena AR, Panayiotopoulos C, et al. Neurological syndromes of brucellosis. J Neurol Neurosurg Psychiatry. 1988;51(8):1017\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"680_CR21","unstructured":"Lulu A, Araj G, Khateeb M, et al. Human brucellosis in Kuwait: a prospective study of 400 cases. QJM Int J Med. 1988;66(1):39\u201354."},{"issue":"1","key":"680_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000165347","volume":"61","author":"G Kutlu","year":"2008","unstructured":"Kutlu G, Ertem GT, Coskun O, et al. Brucella: a cause of peripheral neuropathy. Eur Neurol. 2008;61(1):33\u20138.","journal-title":"Eur Neurol"},{"issue":"10","key":"680_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/sj.sc.3101479","volume":"41","author":"AS Goktepe","year":"2003","unstructured":"Goktepe AS, Alaca R, Mohur H, et al. Neurobrucellosis and a demonstration of its involvement in spinal roots via magnetic resonance imaging. Spinal Cord. 2003;41(10):574\u20136.","journal-title":"Spinal Cord"},{"issue":"3","key":"680_CR24","first-page":"395","volume":"25","author":"MW Al-Sous","year":"2004","unstructured":"Al-Sous MW, Bohlega S, Al-Kawi MZ, et al. Neurobrucellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol. 2004;25(3):395\u2013401.","journal-title":"AJNR Am J Neuroradiol"},{"key":"680_CR25","doi-asserted-by":"crossref","unstructured":"Fincham RW, Sahs AL, Joynt RJ. Protean manifestations of nervous system brucellosis. Case histories of a wide variety of clinical forms. JAMA. 1963;184:269\u201375.","DOI":"10.1001\/jama.1963.03700170061009"},{"key":"680_CR26","doi-asserted-by":"crossref","unstructured":"Olie SE, Andersen C\u00d8, van de Beek D, et al. Molecular diagnostics in cerebrospinal fluid for the diagnosis of central nervous system infections. Clin Microbiol Rev. 2024;37:e00021\u201324.","DOI":"10.1128\/cmr.00021-24"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00680-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00680-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T07:03:09Z","timestamp":1736924589000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00680-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["680"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00680-1","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"30 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients or their legally authorized representatives provided informed consent. This study received approval from the ethics committee of Mashhad University of Medical Sciences under the code IR.MUMS.REC.1400.263.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"Informed consent for publication was obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}